FDA inspection
Halcyon Labs Private Limited: FDA inspection ending Feb 18, 2015
FDA inspection 918937 · No Action Indicated (NAI) · Mumbai
Key facts
| Inspection ID | 918937 |
|---|---|
| Firm | Halcyon Labs Private Limited |
| FEI number | 3006033094 |
| Address | Plot No. 409, Phase - Iv, Gidc, Industrial Estate |
| City | Mumbai |
| Country | India |
| Fiscal year | 2015 |
| Inspection end date | Feb 18, 2015 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data